Completed NA INTERVENTIONAL 2-arm NCT04404855

Antibiotic Selection Using Next Generation Sequencing vs Urine Culture (ACCESS)

Randomized Clinical Trial Using Next Generation Microbial Sequencing to Direct Antibiotic Selection Before Kidney Stone Lithotripsy Using an Interprofessional Model

Sponsor: Microgen LLC

Conditions Infection, Bacterial Kidney Stone Renal Stone

Interventions NGS + Antibiotic Recommendation Standard of Care treatment

Updated 8 times since 2020 Last updated: Mar 11, 2024 Started: Dec 18, 2019 Primary completion: Jan 31, 2022 Completion: Aug 31, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Infection, Bacterial and Kidney Stone and is currently completed. Microgen LLC leads this study, which shows 8 recorded versions since 2019 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

8 versions recorded

Feb 2025 — Present [monthly]

Completed NA
Sep 2024 — Feb 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Apr 2024 — Jul 2024 [monthly]

Completed NA

Status: Unknown Status → Completed
Aug 2023 — Apr 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status

▶ Show 3 earlier versions

Sep 2021 — Aug 2023 [monthly]

Recruiting NA
Jan 2021 — Sep 2021 [monthly]

Recruiting NA
Jun 2020 — Jan 2021 [monthly]

Recruiting NA

First recorded

Dec 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Microgen LLC
The University of Texas Health Science Center at San Antonio

Data source: The University of Texas Health Science Center at San Antonio

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• San Antonio, United States